Featured Research

from universities, journals, and other organizations

Popular heart drug may be unsafe for some kidney patients

Date:
June 25, 2010
Source:
American Society of Nephrology
Summary:
For patients with kidney disease on dialysis, the widely used heart medication digoxin may lead to an increased risk of premature death, according to a new study.

For patients with kidney disease on dialysis, the widely used heart medication digoxin may lead to an increased risk of premature death, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

The researchers monitored more than 120,000 dialysis patients drawn from over 1,800 clinics across North America for up to four years. "We were surprised to find that digoxin use increased death risk in dialysis patients, especially in patients on higher doses," comments Kevin Chan, MD, MSci, Fresenius Medical Care North America, Waltham, MA.

The risk of death was 28 percent higher for dialysis patients taking digoxin, after adjustment for other factors. The increase in risk was greater for patients with higher levels of digoxin in their blood and in patients who had lower serum potassium levels, which is a well-known factor that contributes to digoxin toxicity.

Over 400,000 Americans currently live with dialysis for end-stage renal disease, which in itself, magnifies the risk for concurrent heart disease. When heart disease is present, it is sometimes treated with digoxin, for the of regulation heart rate in atrial fibrillation or the augmentation of overall pump function in heart failure.

Four percent of dialysis patients in the study were taking digoxin. "Although digoxin has been prescribed by doctors for over 200 years, widespread monitoring studies have not been conducted to examine the penetration, effectiveness, and safety of the drug among patients on dialysis," says Dr. Chan.

The new and national study raises concern that digoxin could in fact be dangerous when used in kidney disease patients on dialysis. However, Dr. Chan emphasizes that since the study was based on clinical surveillance data, the findings cannot be considered conclusive. "Further research is needed to outline how and if digoxin can be safely prescribed in patients on hemodialysis," he says.

In the meantime, Dr. Chan encourages doctors, patients, and healthcare providers to reconsider the benefits of digoxin when alternative treatments are available for heart disease in patients starting dialysis. He adds, "For patients who remain on digoxin, vigilant monitoring of digoxin and potassium blood levels can minimize the drug's possible side effects."

Study co-authors were Raymond Hakim, M.D., Ph.D. and Michael Lazarus, M.D. (Fresenius Medical Care North America, Waltham, MA).


Story Source:

The above story is based on materials provided by American Society of Nephrology. Note: Materials may be edited for content and length.


Journal Reference:

  1. Kevin Chan, Raymond Hakim, Michael Lazarus. Digoxin Associates with Mortality in ESRD. Journal of the American Society of Nephrology, 2010; DOI: 10.1681/ASN.2009101047

Cite This Page:

American Society of Nephrology. "Popular heart drug may be unsafe for some kidney patients." ScienceDaily. ScienceDaily, 25 June 2010. <www.sciencedaily.com/releases/2010/06/100624183009.htm>.
American Society of Nephrology. (2010, June 25). Popular heart drug may be unsafe for some kidney patients. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2010/06/100624183009.htm
American Society of Nephrology. "Popular heart drug may be unsafe for some kidney patients." ScienceDaily. www.sciencedaily.com/releases/2010/06/100624183009.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Microneedle Patch Promises Painless Pricks

Microneedle Patch Promises Painless Pricks

Reuters - Innovations Video Online (Oct. 18, 2014) Researchers at The National University of Singapore have invented a new microneedle patch that could offer a faster and less painful delivery of drugs such as insulin and painkillers. Video provided by Reuters
Powered by NewsLook.com
Raw: Nurse Nina Pham Arrives in Maryland

Raw: Nurse Nina Pham Arrives in Maryland

AP (Oct. 17, 2014) The first nurse to be diagnosed with Ebola at a Dallas hospital walked down the stairs of an executive jet into an ambulance at an airport in Frederick, Maryland, on Thursday. Pham will be treated at the National Institutes of Health. (Oct. 16) Video provided by AP
Powered by NewsLook.com
Raw: Cruise Ship Returns to US Over Ebola Fears

Raw: Cruise Ship Returns to US Over Ebola Fears

AP (Oct. 17, 2014) A Caribbean cruise ship carrying a Dallas health care worker who is being monitored for signs of the Ebola virus is heading back to Texas, US, after being refused permission to dock in Cozumel, Mexico. (Oct. 17) Video provided by AP
Powered by NewsLook.com
Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

AFP (Oct. 17, 2014) All four suspected Ebola cases admitted to hospitals in Spain on Thursday have tested negative for the deadly virus in a first round of tests, the government said Friday. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins